Pneumococcal polysaccharide vaccine (23-valent) vs Immunosuppressants

Interacting Drugs
Pneumococcal polysaccharide vaccine (23-valent)
vs
Immunosuppressants
Security Level
Minor, Monitor Therapy
Mechanism
Immunosuppressants: May diminish the therapeutic effect of Vaccines (Inactivated). Exceptions: Cytarabine (Liposomal).
Management
Monitor therapy

Subscribe for latest updates

Subscribe to our e-mail newsletter to receive updates.

No comments yet.

Post Review about Pneumococcal polysaccharide vaccine (23-valent) vs Immunosuppressants